We thank Sue Candy, Michelle Potgieter, and Andrew Whitelaw for assistance with the data and helpful comments. The authors thank Jacob Bor, Sean Wasserman, Josh Wilde, and two anonymous reviewers for helpful comments. The authors thank Yubraj Acharya, David Ederer, Kathryn Fischer, Gaurav Khanna, Yi Mao, Alex Russov, Ryoko Sato, Reinhard Schiel, Kristefer Stojanovski, Will Story, Ben Thompson, Samuel Tzou, Jifang Zhou, and Sasha Zhou for research assistance.
Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S, 2005. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis 191: 150–158.
Getahun H, Gunneberg C, Granich R, Nunn P, 2010. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50: S201–S207.
WHO, 2017. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization.
Statistics South Africa, 2013. Mortality and Causes of Death in South Africa, 2010: Findings from Death Notification. Pretoria, South Africa: Statistics South Africa. Available at: http://www.statssa.gov.za/publications/p03093/p030932010.PDF. Accessed September 17, 2015.
Bor J, Herbst AJ, Newell ML, Bärnighausen T, 2013. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339: 961–965.
Nanoo A, Izu A, Ismail NA, Ihekweazu C, Abubakar I, Mametja D, Madhi SA, 2015. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis. Lancet Infect Dis 15: 1066–1076.
Havlir DV, Getahun H, Sanne I, Nunn P, 2008. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 300: 423–430.
Lawn SD, Harries AD, Williams BG, Chaisson RE, Losina E, De Cock KM, Wood R, 2011. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis 15: 571–581.
Karim SS, Churchyard GJ, Karim QA, Lawn SD, 2009. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 374: 921–933.
McLaren ZM, Sharp AR, Zhou J, Wasserman S, Nanoo A, 2017. Assessing healthcare quality using routine data: evaluating the performance of the national tuberculosis programme in South Africa. Trop Med Int Health 22: 171–179.
Wood R, Lawn SD, 2011. Antiretroviral treatment as prevention: impact of the ‘test and treat’ strategy on the tuberculosis epidemic. Curr HIV Res 9: 383–392.
Girardi E Antiretroviral Therapy Cohort Collaboration, 2005. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 41: 1772–1782.
Middelkoop K, Bekker LG, Myer L, Whitelaw A, Grant A, Kaplan G, McIntyre J, Wood R, 2010. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 182: 1080–1085.
Pretorius C 2014. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS 28: S25–S34.
Suthar AB 2012. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 9: e1001270.
Williams BG, Granich R, De Cock KM, Glaziou P, Sharma A, Dye C, 2010. Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci USA 107: 19485–19489.
Bassett IV, Wang B, Chetty S, Giddy J, Losina E, Mazibuko M, Bearnot B, Allen J, Walensky RP, Freedberg KA, 2010. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823–829.
Zachariah R 2011. Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis 15: 933–937.
Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S, 2006. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 43: 42–46.
April MD, Wood R, Berkowitz BK, Paltiel AD, Anglaret X, Losina E, Freedberg KA, Walensky RP, 2014. The survival benefits of antiretroviral therapy in South Africa. J Infect Dis 209: 491–499.
National Treasury South Africa, 2007. Provincial Budgets and Expenditure Review: 2003/04–2009/10. Pretoria, South Africa. Available at: http://www.treasury.gov.za/publications/igfr/2007/prov/00.%20Front%20Pages%20and%20Contents.PDF. Accessed September 17, 2015.
Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S, 2012. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7: e36966.
Rosen S, Ketlhapile M, Sanne I, DeSilva MB, 2008. Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa. J Int Assoc Physicians AIDS Care (Chic) 7: 200–207.
World Health Organization, 2008. Molecular Line Probe Assays for Rapid Screening of Patients at Risk of Multidrug-Resistant Tuberculosis. Geneva, Switzerland: World Health Organization.
Houben RM, Glynn JR, Mboma S, Mzemba T, Mwaungulu NJ, Mwaungulu L, Mwenibabu M, Mpunga J, French N, Crampin AC, 2012. The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting. AIDS 26: 2233–2239.
Dodd PJ, Knight GM, Lawn SD, Corbett EL, White RG, 2013. Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis. PLoS One 8: e75466.
Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, Wiysonge CS, Mataya RH, 2007. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in southern Africa: a systematic review. BMC Public Health 7: 63.
Wouters E, Heunis C, Ponnet K, Van Loon F, le Roux Booysen F, van Rensburg D, Meulemans H, 2010. Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation. BMC Public Health 10: 387.
Reid MJ, Shah NS, 2009. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 9: 173–184.